Search Within

Neerav Shukla

Formats
  1. Journal Article (77)
  2. Meeting Abstract (74)
  3. Review (5)
  4. Research Letter (3)
  5. Editorial (2)
Groups
  1. Center for Hematologic Malignancies (161)
  2. Hematologic Malignancies Service (161)
  3. Pediatric Leukemia (161)
  4. Pediatrics, Department of (161)
  5. GSK Faculty (88)
  6. Tow Center for Developmental Oncology (TCDO) (83)

More Groups

People
  1. Marc Ladanyi (42)
  2. Peter Steinherz (36)
  3. Rachel Kobos (31)
  4. Andrew Kung (27)
  5. Michael Berger (22)
  6. Michael Walsh (19)

More People

Years
  1. 2025 (5)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (14)
  5. 2021 (12)
  6. 2020 (11)

More Years

Publications
  1. Blood (27)
  2. Pediatric Blood and Cancer (20)
  3. Journal of Clinical Oncology (16)
  4. Clinical Cancer Research (8)
  5. JCO Precision Oncology (8)
  6. Cancer Research (7)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. American Society of Clinical Oncology (24)
  3. Wiley Periodicals, Inc (20)
  4. American Association for Cancer Research (18)
  5. Nature Publishing Group (12)
  6. Oxford University Press (10)

More Publishers

Results (161)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
    Journal Article

    Issa, G. C.; Aldoss, I.; DiPersio, J.; Cuglievan, B.; Stone, R.; Arellano, M.; Thirman, M. J.; Patel, M. R.; Dickens, D. S.; Shenoy, S.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study
    Journal Article

    Abramson, D. H.; Mandelker, D. L.; Brannon, A. R.; Dunkel, I. J.; Benayed, R.; Berger, M. F.; Arcila, M. E.; Ladanyi, M.; Friedman, D. N.; Jayakumaran, G.; more...
    PLoS ONE (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Unmatched whole-genome sequencing as a clinical tool for hematological neoplasms with significant utility in cases with tumor-in-normal contamination
    Meeting Abstract

    Gutiérrez-Abril, J.; Leongamornlert, D.; Shukla, N. N.; Sulis, M. L.; Zhou, Y.; Levine, M. F.; Barretta, E.; Lee, S.; Arango-Ossa, J. E.; Gundem, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The menin inhibitor SNDX-5613 (revumenib) leads to durable responses in patients (Pts) with KMT2A-rearranged or NPM1 mutant AML: Updated results of a phase (Ph) 1 study
    Meeting Abstract

    Issa, G. C.; Aldoss, I.; DiPersio, J. F.; Cuglievan, B.; Stone, R. M.; Arellano, M. L.; Thirman, M. J.; Patel, M. R.; Dickens, D.; Shenoy, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Outcomes of MSK-NY-II therapy in pediatric and young adult patients with precursor B-cell acute lymphoblastic leukemia
    Meeting Abstract

    Ramaswamy, K.; Forlenza, C.; Shukla, N.; Trippett, T.; Sulis, M. L.; Steinherz, P.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL): Results from the phase 2 DELPHINUS study
    Meeting Abstract

    Hogan, L. E.; Bhatla, T.; Teachey, D. T.; Sirvent, F. J. B.; Moppett, J.; Puyó, P. V.; Micalizzi, C.; R?Ssig, C. R.; Shukla, N.; Gilad, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma
    Review

    Shulman, D. S.; Whittle, S. B.; Surdez, D.; Bailey, K. M.; de Álava, E.; Yustein, J. T.; Shlien, A.; Hayashi, M.; Bishop, A. J. R.; Crompton, B. D.; more...
    npj Precision Oncology (2022)

    Fulltext@MSK | Save